(Q51089201)

English

Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval?

scientific article published in June 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

Harmonising and competing for medicines regulation: how healthy are the European Union's systems of drug approval? (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

author name string

Abraham J

1

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

Lewis G

2

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

language of work or name

0 references

publication date

1 June 1999

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

Social Science and Medicine

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

48

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

11

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

1655-1667

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

The Drug Lag Issue: The Debate Seen from an International Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2899%2900042-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Differing attitudes of industry and academia towards controlled clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2899%2900042-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug makers and drug regulators: too close for comfort. A study of the Canadian situation

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2899%2900042-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Who needs faster drug approval times in Canada: the public or the industry?

1 reference

https://api.crossref.org/works/10.1016%2FS0277-9536%2899%2900042-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0277-9536(99)00042-8

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

release_htqwkquxr5ayphlkiy7el3rqdi

1 reference

https://api.fatcat.wiki/v0/release/htqwkquxr5ayphlkiy7el3rqdi

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 March 2018

http://europepmc.org/abstract/MED/10400264

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51089201&oldid=1838398730"